Biohealthmatics.com The 24th annual conference TEPR 2008 will open its doors on May 19, 2008 at the Fort Lauderdale Convention Center to more than 500 speakers, close to 5,000 attendees, and approximately 200 exhibitors.
advertisement
Sign Up  
Biohealthmatics Centers
Home
Jobs Search
Career Center
Networking Center
Company Profiles
Knowledge Center
Industry News
Web Directory
Industry Books
Featured Articles

Biohealthmatics.com....linking professionals
advertisement

Join Us

Link To Us





Jobs Search Home - Companies Categories



Enzon Pharmaceuticals
Address: 685 Route 202/206
Bridgewater
NJ
United States
08807
Phone Number: 908-541-8600
Website: http://www.enzon.com/
Ownership: Public – ENZN (NASDAQ)

Company Overview:
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that is involved in the discovery, development, manufacture, and commercialization of human therapeutics for life threatening diseases.

Products and Services:
Enzon’s markets ABELCET, ONCASPAR, ADAGEN, and DEPOCYT in North America. In addition, it also receives royalties on sales of PEG-INTRON, marketed by Schering-Plough Corporation, and MACUGEN, marketed by Eyetech Pharmaceuticals and Pfizer Inc.

Key Personnel Facts:
300 employees.

Key Financial Facts:
Total revenue of 166 million USD in the financial year ending June 2005.


Back to Top


Working @ Enzon Pharmaceuticals
Have your shout about working or interveiwing at Enzon Pharmaceuticals

1 message posted

Message Posted:
Working @ Enzon Pharmaceuticals
Share your experiences about working, interviewing or applying for a job at Enzon ...
Author: Obi Posted: 10/20/2005 10:48:32 AM

View or add comments about Enzon Pharmaceuticals

Back to Top


Enzon Pharmaceuticals in the News

View more news about Enzon Pharmaceuticals

Back To Top

 

Categories:
Biotechnology

 

Back to Top


 

 
   
Copyright © 2007 Biohealthmatics.com. All Rights Reserved. Contact Us - About Us - Privacy Policy - Terms & Conditions - Resources
Can't find what you are looking for? View our Site Map

Last Updated: 28 December 2007.